Hyphens Pharma International Limited (SGX:1J5)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.3350
0.00 (0.00%)
At close: Feb 27, 2026

SGXC:1J5 Cash Flow Statement

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
5.8410.198.5711.356.85
Depreciation & Amortization
2.813.062.82.722.2
Loss (Gain) From Sale of Assets
0.09-0.01-0.0100
Loss (Gain) From Sale of Investments
---0.17--
Loss (Gain) on Equity Investments
---0.55-0.47-0.02
Other Operating Activities
1.351.3-0.771.130.47
Change in Accounts Receivable
10.45-4.18-9.24-2.56-1.99
Change in Inventory
5.11-8.92-3.524.03-4.61
Change in Accounts Payable
-5-0.929.650.843.11
Change in Other Net Operating Assets
-1.91-0.47-1.13-0.170.02
Operating Cash Flow
18.750.065.6516.886.04
Operating Cash Flow Growth
31146.67%-98.94%-66.55%179.51%46.20%
Capital Expenditures
-0.76-1.18-0.3-0.56-0.7
Sale of Property, Plant & Equipment
-0.010.010-
Cash Acquisitions
-3.42--0.750.18-14.16
Sale (Purchase) of Intangibles
-0.5-2-0.9-0.76-0.13
Investment in Securities
---0.03-
Other Investing Activities
0.060.150.460.10.07
Investing Cash Flow
-4.62-3.02-1.48-1.01-14.92
Long-Term Debt Issued
12.99.01-54.24
Long-Term Debt Repaid
-17.77-2.82-2.5-7.64-1.47
Net Debt Issued (Repaid)
-4.876.19-2.5-2.642.77
Repurchase of Common Stock
-0-0.09---
Common Dividends Paid
-5.48-2.66-14.56-2.07-1.86
Other Financing Activities
-0.36-0.44-0.215.86-0.1
Financing Cash Flow
-10.723.01-17.281.150.81
Net Cash Flow
3.410.05-13.1117.02-8.07
Free Cash Flow
17.99-1.125.3416.325.34
Free Cash Flow Growth
---67.27%205.77%41.98%
Free Cash Flow Margin
10.14%-0.57%3.13%10.05%4.24%
Free Cash Flow Per Share
0.06-0.000.020.050.02
Cash Interest Paid
0.360.340.210.240.1
Cash Income Tax Paid
2.432.352.62.151.42
Levered Free Cash Flow
18.64-7.032.0114.57-0.74
Unlevered Free Cash Flow
18.97-6.682.1814.71-0.68
Change in Working Capital
8.66-14.49-4.242.14-3.46
Source: S&P Global Market Intelligence. Standard template. Financial Sources.